chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Pruritus, Rash macular
Clinical narrative: Red blotchy, hot, and itchy face; Red blotchy, hot, and itchy face; Red blotchy, hot, and itchy face; This is a spontaneous report received from a non-contactable consumer, the patient. A 29-years-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7534) via unspecified route of administration in left arm on 19Mar2021 at 15:45 (at the age of 29 years old) for COVID-19 immunisation. Patients past drug history included first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: not known) via unspecified route of administration in left arm on unspecified date for COVID-19 immunisation. Medical history was not reported. Patient received concomitant medications, However names not specified (although it was stated that patient had received medications within 2 weeks of vaccination). The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient had no allergies to medications, food, or other products.  The patient experienced red blotchy, hot, and itchy face on 19Mar2021 at 16:30. Treatment was not received for the adverse events.   Clinical outcome of the red blotches, feeling of warmth facial, facial pruritis was recovering.  No follow-up attempts are needed. No further information is expected.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Rash, Vaccination site erythema, Vaccination site pain
Clinical narrative: pain at vaccination site; headache; Rash on entire chest area; Vaccination site redness; Rash on face; This is a spontaneous report received from contactable consumer, the patient. A 25-year-female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8727) via an unspecified route of administration in the left arm on19Mar2021 at 15:45 (at the age of 25-year-old), as a single dose for COVID-19 immunisation. The patient did not had any medical history. The patient's concomitant medications included buspirone(MANUFACTURER UNKNOWN), ibuprofen(MANUFACTURER UNKNOWN), excedrin(MANUFACTURER UNKNOWN) from an unknown date for an unknown indication. The patient previously received first dose of BNT162B2(PFIZER BIONTECH COVID-19 mRNA VACCINE; Lot No:En6200),via an unspecified route of administration in the left arm on 26Feb2021 at 16:00 (at the age of 25-year-old)as a single dose for COVID-19 immunisation. The patient had allergies to thimerosal, T-Dap and tubersol. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Mar2021 at 16:30, the patient experienced rash on entire chest area within 45 minutes of shot, spread to face within an hour, pain at vaccination site along with redness and headache. Therapeutic measures were taken as the result of events was unknown. The clinical outcome of the event rash on entire chest area, pain at vaccination site along with redness and headache was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia
Clinical narrative: My mouth had a metallic taste.; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non pregnant female patient received first dose of BNT162b2(PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6205), via unspecified route of administration, administered in left arm on 19Mar2021 at 14:45 (at the age of 37 years old) as a single dose for COVID-19 immunisation. Medical history included svt, asthma. Concomitant medication included BYSTOLIC, ADVAIR, PROTONIX, vitamin d (MANUFACTURER UNKNOWN), and TYLENOL for unknown indication and unknown duration. The patient reported of allergic reaction to food but not exactly sure about the ingredient that caused. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient was not diagnosed with COVID 19 prior to vaccination. Since the vaccination patient had not been tested for COVID-19. The patient experienced metallic taste in mouth on 19Mar2021 at 15:00. The clinical outcome of the event metallic taste was unknown at the time of reporting.   No follow up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Pain, Pyrexia
Clinical narrative: Severe headache; body aches; fatigue; mild fever; chills; This is a spontaneous report from a contactable consumer. A 58 year old non pregnant female patient received unknown dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Batch Number: EL-3247), via unspecified route of administration in the left arm on 15Mar2021 at 02:30 PM (at the age of 58 years) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not included. The Patient was allergic to Morphine. The patient did not receive any other vaccine within 4 weeks prior to the vaccine.  On 15Mar2021 at 09:00PM, the patient experienced events severe headache, body aches, fatigue, mild fever and chills. The Clinical outcomes of events severe headache, body aches, fatigue, mild fever and chills were recovered on unknown dates. The patient had not tested positive for COVID-19 since the vaccination. No follow-up attempts are possible. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Chills, Diarrhoea, Influenza like illness, Pain
Clinical narrative: Stomachache; diarrhea very liquid stools; Feel flu like symptoms; Achy; Chills; Very sleepy; This is a spontaneous report from a contactable Consumer, the patient. A 60-years-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: Unknown) (at the age 60 years) via an unspecified route of administration, on the left arm, on 18Mar2021 at 13:30 as a single dose for COVID-19 immunisation. The patient medical history includes diabetes, high blood pressure, thyroid and glaucoma. Concomitant medications include Bystolic [MANUFACTURER UNKNOWN], amlodipine [MANUFACTURER UNKNOWN], synthroid [MANUFACTURER UNKNOWN], allopurinol [MANUFACTURER UNKNOWN], and spiron [MANUFACTURER UNKNOWN], for unknown indications. The patient was allergic to Pineapples, stations and ceclore. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 19Mar2021 at 10:00 AM, the patient experienced achy, chills, diarrhoea very liquid stools, flu-like symptoms, stomach-ache and very sleepy. No treatment was received to treat adverse events. The clinical outcome of the events stomach-ache, watery diarrhoea, flu-like symptoms, ache, chills, and sleepy was reported as not resolved at the time of reporting. Information about lot/batch number cannot be obtained. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Somnolence
Clinical narrative: Stomachache; diarrhea very liquid stools; Feel flu like symptoms; Achy; Chills; Very sleepy; This is a spontaneous report from a contactable Consumer, the patient. A 60-years-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: Unknown) (at the age 60 years) via an unspecified route of administration, on the left arm, on 18Mar2021 at 13:30 as a single dose for COVID-19 immunisation. The patient medical history includes diabetes, high blood pressure, thyroid and glaucoma. Concomitant medications include Bystolic [MANUFACTURER UNKNOWN], amlodipine [MANUFACTURER UNKNOWN], synthroid [MANUFACTURER UNKNOWN], allopurinol [MANUFACTURER UNKNOWN], and spiron [MANUFACTURER UNKNOWN], for unknown indications. The patient was allergic to Pineapples, stations and ceclore. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 19Mar2021 at 10:00 AM, the patient experienced achy, chills, diarrhoea very liquid stools, flu-like symptoms, stomach-ache and very sleepy. No treatment was received to treat adverse events. The clinical outcome of the events stomach-ache, watery diarrhoea, flu-like symptoms, ache, chills, and sleepy was reported as not resolved at the time of reporting. Information about lot/batch number cannot be obtained. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain, Pain in extremity, Vaccination site pain, Vaccination site rash
Clinical narrative: circular rash m/spot at the site; pain to the site; excruciating pain to the entire left arm and neck; excruciating pain to the entire left arm and neck; This is a spontaneous report received from a contactable nurse. A 40-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no. EN6198) via an unspecified route of administration in the left arm on 06Mar2021 at 09 15, as a single dose for COVID-19 immunisation. Medical history included asthma and migraines. Concomitant medications included TYLENOL, SYMBICORT, albuterol (UNKNOWN MANUFACTURER UNKNOWN), ZYRTEC taken within 2 weeks of vaccination. The patient had allergies to aspirin and NSAIDS. Prior to vaccination, patient was not diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient has not been tested positive for COVID- 19. On 17Mar2021, the patient experienced pain at site and excruciating pain in the entire left arm and neck, also noticed a circular rash m/spot at the site on 18Mar2021 which got larger on 19Mar2021. The clinical outcome of vaccination site pain, vaccination site rash, excruciating pain to the entire left arm and neck was not recovered.   No follow-up attempts are needed. No further information is expected
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Cystitis
Clinical narrative: Bladder infection; This is a spontaneous report from a contactable consumer (patient).  This 58-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number ET6955 with Expiration Date Jul2021), via an unknown route, on 19Mar2021 (at the age of 59-year-old) as single dose for COVID-19 immunisation. No relevant medical history and concomitant medications were provided. After vaccine, in Mar2021, the patient had bladder infection. The event was reported as non-serious. She was consuming water and Cranberry juice for bladder infection. She was also prescribed nitrofurantoin 100 mg. The outcome of the event was unknown.  No follow-up attempts are needed. No further information is expected.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Feeling abnormal, Headache
Clinical narrative: Fever; pain at injection site; joint pain; chills; tiredness; nausea; muscle pain; feeling bad; headache; This is a spontaneous report from a contactable consumer.   A 51-years-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE),  via an unspecified route of administration, administered in arm left on 19Mar2021 13:00 (Batch/Lot Number: EN6207) (at the age of 51) as single dose for covid-19 immunisation. Medical history was not reported. No concomitant medications in two weeks. No other vaccine in four weeks. No covid tested post vaccination. The patient experienced fever on 20Mar2021 01:00, pain at injection site on 20Mar2021 01:00, joint pain on 20Mar2021 01:00, chills on 20Mar2021 01:00, tiredness on 20Mar2021 01:00, nausea on 20Mar2021 01:00, muscle pain on 20Mar2021 01:00, feeling bad on 20Mar2021 01:00, headache on 20Mar2021 01:00. The events were not treated. The events outcome was not recovered.    No follow-up attempts are possible. No further information is expected.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pyrexia, Vaccination site pain
Clinical narrative: Fever; pain at injection site; joint pain; chills; tiredness; nausea; muscle pain; feeling bad; headache; This is a spontaneous report from a contactable consumer.   A 51-years-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE),  via an unspecified route of administration, administered in arm left on 19Mar2021 13:00 (Batch/Lot Number: EN6207) (at the age of 51) as single dose for covid-19 immunisation. Medical history was not reported. No concomitant medications in two weeks. No other vaccine in four weeks. No covid tested post vaccination. The patient experienced fever on 20Mar2021 01:00, pain at injection site on 20Mar2021 01:00, joint pain on 20Mar2021 01:00, chills on 20Mar2021 01:00, tiredness on 20Mar2021 01:00, nausea on 20Mar2021 01:00, muscle pain on 20Mar2021 01:00, feeling bad on 20Mar2021 01:00, headache on 20Mar2021 01:00. The events were not treated. The events outcome was not recovered.    No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Heart rate, Heart rate increased
Clinical narrative: fast heartbeat; This is a spontaneous report from a non-contactable consumer (patient). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on 19Mar2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation.  The patient medical history and concomitant medications were not reported.  The patient experienced fast heartbeat (non-serious) on Mar2021. The patient underwent lab tests and procedures which included heart rate on Mar2021: fast heartbeat (at night, she had a fast heartbeat).  The outcome of the event was unknown.   No follow up attempts are possible; Information about Lot/batch number cannot be obtained.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Movement disorder, Pain in extremity
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 78-years-old male patient received BNT162B2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 23Feb2021 15:00 (Batch/Lot Number: EN6203) age at vaccination of 78-years-old, as single dose and dose 2 via an unspecified route of administration, administered in Arm Left on 16Mar2021 15:00 (Batch/Lot Number: ER2613) as 2ND DOSE, SINGLE DOSE for COVID-19 immunization.  Medical history included hypersensitivity from an unknown date and unknown if ongoing (Erythromycin and iodine contrast fluid). Concomitant medications included lisinopril (LISINOPRIL) taken for an unspecified indication, start and stop date were not reported; pravastatin (PRAVASTATIN) taken for an unspecified indication, start and stop date were not reported. After 5 weeks from vaccination the patient still experienced pain in upper arm, severe pain in left shoulder with limited use of arm/inability to freely move arm. Physician Office Visit was required and MD prescribed lidocaine patch (that not help) and now patient was taking Prednisone pack. May require orthopedic intervention. The patient was not recovered from the events.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Rash macular
Clinical narrative: I developed a red spot on my arm the following day and it has doubled in size the next day.; This is a spontaneous report from contactable consumer (patient).   A 37-years-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left on 18Mar2021 16:00 (Batch/Lot Number: ER8727) (at the age of 37) as single dose for covid-19 immunisation. Medical history included rheumatoid arthritis from an unknown date and unknown if ongoing, amoxicillin hypersensitivity from an unknown date and unknown if ongoing,  latex adhesive sensitivity from an unknown date and unknown if ongoing. Concomitant medications included meloxicam and tofacitinib citrate (XELJANZ). The patient experienced red spot on her arm the following day and it has doubled in size the next day on 19Mar2021 14:00. No treatment received. The  outcome was not recovered.    Additional information:  vaccination: No covid prior vaccination or covid tested post vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Influenza like illness, Pain, Pyrexia, SARS-CoV-2 test
Clinical narrative: Flu like body aches; Flu like body aches; low fever; This is a spontaneous report from a contactable consumer (patient).  A 58-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 10Mar2021 16:45 (Lot Number: EN6207), at vaccination age of 58 years, as single dose for covid-19 immunisation.  The patient did not receive other vaccine in four weeks. Medical history included High BP treatment and Known allergies: Penicillin and Sulfa. Concomitant medications included bupropion hydrochloride (WELLBUTRIN); sertraline hydrochloride (ZOLOFT); lamotrigine; ezetimibe, simvastatin (VYTORIN); amlodipine besilate, olmesartan medoxomil (AZOR), all taken for an unspecified indication, start and stop date were not reported.  On 19Mar2021 04:00 the patient experienced flu like body aches and low fever. The patient did not receive treatment for the events. The events resulted in Doctor or other healthcare professional office/clinic visit. The events were non-serious with outcome of recovering. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 19Mar2021 (Nasal Swab). No covid prior vaccination. No follow-up attempts are possible. No further information is expected.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site mass
Clinical narrative: husband now has a lump that is pretty good in size at the injection site.; This is a spontaneous report from a contactable consumer. This consumer reported for her husband. A 58-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 17Mar2021 (Batch/Lot number was not reported), at vaccination age of 58 years,  as single dose for covid-19 immunisation.  The patient medical history and concomitant medications were not reported.  The patient experienced a lump that is pretty good in size at the injection site (non-serious) on Mar2021 with outcome of unknown. No follow-up attempts are possible. Information about Lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pyrexia
Clinical narrative: fever; headache; chills; This is a spontaneous report from a Pfizer-sponsored program from a contactable consumer (patient's daughter)  A female patient of an unspecified age received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 19Mar2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. Patient received the first dose on an unknown date. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced fever on Mar2021, headache on Mar2021, chills on Mar2021. The events outcome was unknown.    No follow-up attempts are possible; information about lot/batch number cannot be obtained
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Hives on back of upper arm; This is a spontaneous report from a non-contactable consumer, the patient. A 23-year-old female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613), via an unspecified route of administration on16Mar2021(at the age of 23-year-old), as a single dose for COVID-19 immunisation. The patients medical history and Concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not tested for COVID-19. On 17Mar2021, the patient experienced hives on back of upper arm. The clinical outcome of the event hives on back of upper arm was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Chills, Fatigue, Headache, Pain
Clinical narrative: Soreness at the site injection,; fatigue; chills; body aches; stomach pains; headache; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA vaccine; Lot number: EL3247), via an unspecified route of administration in the left arm on 16Mar2021 at 09:45am (at the age of 43 years) as a single dose for COVID-19 immunisation. Medical history was not reported. Previously the patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA vaccine; Lot number: EL3247), via an unspecified route of administration in the left arm on 22Feb2021 at 14:30 as a single dose for COVID-19 immunisation. Patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Patient had not received any other medications within 2 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient did not have any known allergies to medications, food, or other products at the time of the report. On 16Mar2021, the patient experienced soreness at the site injection (vaccination site pain), fatigue, chills, and body aches, (about 12 hours after receiving the vaccine) and stomach pains and headache. She also had stomach pains and a headache that lasted for about a day and a half. The patient did not receive treatment for the events. The clinical outcome of the events, vaccination site pain, fatigue, chills, body aches, stomach pains and headache were resolved at an unknown date. No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Soreness at the site injection,; fatigue; chills; body aches; stomach pains; headache; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA vaccine; Lot number: EL3247), via an unspecified route of administration in the left arm on 16Mar2021 at 09:45am (at the age of 43 years) as a single dose for COVID-19 immunisation. Medical history was not reported. Previously the patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA vaccine; Lot number: EL3247), via an unspecified route of administration in the left arm on 22Feb2021 at 14:30 as a single dose for COVID-19 immunisation. Patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Patient had not received any other medications within 2 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient did not have any known allergies to medications, food, or other products at the time of the report. On 16Mar2021, the patient experienced soreness at the site injection (vaccination site pain), fatigue, chills, and body aches, (about 12 hours after receiving the vaccine) and stomach pains and headache. She also had stomach pains and a headache that lasted for about a day and a half. The patient did not receive treatment for the events. The clinical outcome of the events, vaccination site pain, fatigue, chills, body aches, stomach pains and headache were resolved at an unknown date. No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle spasms
Clinical narrative: I am having muscle cramping all over my body within 24 hours; This is a spontaneous report received from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in left arm on 17Mar2021 at 14:45 (at the age of 60-years-old), as a single dose for COVID-19 immunisation. The patient medical history included COVID-19 prior to vaccination. Concomitant medication included Levothyroxine (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) via an unspecified route of administration in left arm on an unknown date, as a single dose for COVID-19 immunisation. The patient did not have any allergies to food, medications, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested positive for COVID-19. On 18Mar2021 at 12:00, the patient experienced muscle cramping all over her body within 24 hours. The patient did not receive any treatment for the event. The clinical outcome of event muscle cramp was not recovered at the time of reporting.   Information about lot/batch number cannot be obtained. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: soreness at injection site; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received her second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3248) via an unspecified route of administration at right arm on 27Feb2021 at 11:00 as a single dose, for COVID-19 immunisation. Medical history and concomitant medications not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3247) via an unspecified route of administration at right arm on 24Feb2021 at 9:30 as a single dose, for COVID-19 immunisation. Patient is not enrolled in clinical trial. The patient was allergic to sulfa drugs. It was reported that the patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 17Mar2021, the patient experienced soreness at injection site at 14:30. The clinical outcome for the events soreness at injection site was recovering at the time of report.  No follow-up attempts are possible. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: Fever and body aches off; Fever and body aches off; This is a spontaneous report from a non- contactable consumer. A 27-years old non-pregnant-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot Number: EN-6208) in the arm right on 16Mar2021at 11:30 AM (age at vaccination- 27 years old) as a single dose for COVID-19 immunisation. Patient's concomitant medications included birth control pill (MANUFACTURER UNKNOWN), lexapro (MANUFACTURER UNKNOWN), claritin (MANUFACTURER UNKNOWN) for unknown indications from unspecified date. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot Number: EM-9809) in the arm left on 23Feb2021 at 12:00 PM as a single dose for COVID-19 Immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.  Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. The Patient did not have any allergies to medications, food, or other product. On 17Mar2021 at 1:00 PM the patient experienced fever and body aches off and on 24-36 hours following the second vaccination. The patient did not receive treatment for the events. The clinical outcome of fever and body aches were resolved.    No follow-up attempts are needed. No further information is expected.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain
Clinical narrative: I began to have chest pains two days after the injection.  The pain grew increasingly frequent and sharp.; This is a spontaneous report from a contactable Health Care Professional. This is a report received from a sponsored program. A 67 year old female patient received the 1st dose of BNT162B2 (PFIZER BIONTECH mRNA COVID-19 VACCINE; Batch Number: EN6200) on the Left Arm on 19Feb2021 at 13.00 for COVID-19 immunisation by a Doctor. Medical history of the patient included high BP, depression, fatty liver, obesity. Past drug history of the patient included allergies to ibuprophen and diovan. Concomitant medications included atenolol, (MANUFACTURER UNKNOWN), cymbalta, norvasc, hydrodiuril, entocort. The patient was not enrolled in any clinical trial. The patient did not undergo COVID-19 virus test prior to the vaccination. The patient has not been tested positive for COVID -19 since taking the vaccine. On 21Feb2021 i.e. two days after the injection the patient experienced chest pain. The pain grew increasingly frequent and sharp. She described the pain as although it was a familiar pain that she had most of her life whenever her body was under any physical stress, this was the very worst it's ever been. The reaction outcome of the event was recovering. No follow-up attempts are possible. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Hot flush, SARS-CoV-2 test
Clinical narrative: Hot flashes several times a day/night; This is a spontaneous report from a non contactable consumer, the patient. A 39-year-old non-pregnant female patient was received first dose of BNT162B2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; lot number: EN 6206) via an unspecified route of administration in left arm on 12Mar2021 at 13:00 hours for COVID-19 immunisation. Medical history included raynauds. Concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had not tested positive for COVID-19 since the vaccination. On 12Mar2021, at 14:00 hours the patient experienced hot flashes several times a day/night for a full week since she got the first dose. They are tolerable but the patient never had them before. The patient underwent tab tests and procedures, which included COVID-19 virus test on 17Mar2021 and tested negative. No therapeutic measures were taken as a result of adverse event. The clinical outcome of the event hot flashes was not resolved at the time of reporting.    No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling of eyelid
Clinical narrative: Right eyelid is swelling; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6208) via an unspecified route of administration in the left arm on 15Mar2021 at 01:00 PM (at the age of 48-year-old), as a single dose for COVID-19 immunisation. Past medical history included endometriosis and ovarian cyst. The patient was allergic to bactrim. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested positive for COVID-19. Concomitant medication was not provided. The facility where the most recent COVID-19 vaccine was administered was at a hospital. On 16Mar2021 at 07:00 AM, the patient experienced right eyelid swelling and every day it was worsening, on day 4 and patient's eye was almost close. No therapeutic measures were taken for the events. The clinical outcome for the event swelling of eyelid was not recovered at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dyspnoea, Fatigue, Pain in extremity, Pyrexia
Clinical narrative: Shortness of breath; Fatigue; Fever; Arm pain; Dizziness; This is a spontaneous report from a non-contactable consumer, the patient. A 28-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6208) via unspecified route of administration in the left arm, on 17Mar2021 at 13:15 (age at vaccination was 28-year-old), as a single dose for COVID-19 immunisation. Medical history included obesity and allergic to dairy. Concomitant medications included tylenol (MANUFACTURER UNKNOWN) and omeprazole (MANUFACTURER UNKNOWN) for an unknown indication received within 2 weeks of vaccination. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. On 18Mar2021 at 11:00, patient experienced dizziness, fatigue, fever, and arm pain and on 19Mar2021 experienced shortness of breath. No therapeutic measures were taken for the reported events. The clinical outcome for dizziness, fatigue, fever, arm pain and shortness of breath was not recovered. No follow-up attempts are needed. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Ear pain, Oropharyngeal pain, SARS-CoV-2 antibody test
Clinical narrative: Sore throat; Left ear started to hurt; I am really in a lot of pain; This is a spontaneous report from a contactable consumer (patient).  A 29-year-old patient of an unspecified gender received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on 14Mar2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation.  Medical history was none.   The patient's concomitant medications were not reported.  On an unspecified date the patient experienced sore throat, and left ear started to hurt; i am really in a lot of pain. The event sore throat was treated with cough syrup and 2 lozenges. The events were non-serious with outcome of unknown.  The patient underwent lab tests and procedures which included Covid test: negative on unknown date.   No follow-up attempts are possible. Information about Lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Headache, Pyrexia
Clinical narrative: low grade fever; headache; This is a spontaneous report received from a Pfizer sponsored program. A contactable consumer reported for a female patient (wife). A female patient of an unspecified age received the first dose of BNT162B2 (Pfizer-Biontech Covid-19 Vaccine) at single dose, on 19Mar2021, for COVID-19 immunization. On an unspecified date, the patient experienced low grade fever and headache. Clinical outcome of the adverse events was unknown at time of this report.   Follow-up attempt have been completed and no further information is expected. The lot number is not available despite follow-up attempts made.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dysgeusia, Hot flush, Nausea
Clinical narrative: Nausea; Hot flushing; Metallic taste; This is a spontaneous report received from a Pfizer sponsored program. A contactable female consumer (patient) of an unspecified age received the first dose of BNT162B2 (Pfizer-Biontech Covid-19 Vaccine) at single dose, on 16Mar2021, for COVID-19 immunization. Relevant medical history and concomitant medications were unknown. On an unspecified date, in Mar2021, the patient experienced nausea, hot flushing and had metallic taste. Patient took Tylenol and Phenergan after the first dose. Clinical outcome of the adverse events was unknown at time of this report.   Follow-up attempt have been completed and no further information is expected. The lot number is not available despite follow-up attempts made.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Back pain, Hot flush, Nausea, Taste disorder
Clinical narrative: Nausea; Hot flushing; Metallic taste; This is a spontaneous report received from a Pfizer sponsored program. A contactable female consumer (patient) of an unspecified age received the first dose of BNT162B2 (Pfizer-Biontech Covid-19 Vaccine) at single dose, on 16Mar2021, for COVID-19 immunization. Relevant medical history and concomitant medications were unknown. On an unspecified date, in Mar2021, the patient experienced nausea, hot flushing and had metallic taste. Patient took Tylenol and Phenergan after the first dose. Clinical outcome of the adverse events was unknown at time of this report.   Follow-up attempt have been completed and no further information is expected. The lot number is not available despite follow-up attempts made.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Breast pain, Lymphadenopathy
Clinical narrative: Swollen lymph nodes under left arm making left breast sore; Swollen lymph nodes under left arm making left breast sore; This is a spontaneous report from a contactable consumer (patient). A non-pregnant 41-years-old female patient received the first dose of BNT162B2 Pfizer-BioNTech COVID-19 mRNA Vaccine administered via an unspecified route of administration in left arm on 02Mar2021 (Batch/Lot Number: EL3247), at 41 years of age, as single dose for COVID-19 immunization. Medical history was none. The patient didn't receive any concomitant medication and any other vaccine in the previous 4 weeks, she was not diagnosed with COVID-19 prior to vaccination and was not tested for COVID-19 since the vaccination. On an unspecified date in Mar2021 the patient experienced swollen lymph nodes under left arm making left breast sore. The patient didn't receive any treatment for the events. At the time of the report the events had not resolved yet.  No follow-up attempts are needed. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Pain on injection site; This is a spontaneous report from contactable consumer (patient) through a Pfizer sales representative.  A patient of an unspecified age and gender received the first dose of BNT162B2 (Pfizer-Biontech Covid-19 Vaccine,) at single dose, on an unspecified date, for COVID-19 immunization. Relevant medical history and concomitant medications were unknown. On an unspecified date, 8 hours after the vaccination, the patient experienced pain on injection site. Clinical outcome of the adverse event was unknown at time of this report.  No follow-up attempts are possible, information about lot number cannot be obtained.
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Myalgia, Peripheral swelling, Pyrexia
Clinical narrative: fever; fatigue; muscle pain; swelling in the arm; This is a spontaneous report from a contactable consumer (patient).  This patient of unspecified age and gender received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. Relevant medical history and concomitant medications were not reported. The patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unspecified date for COVID-19 immunisation. On an unspecified date, after the second dose of the vaccine, the patient experienced fever, fatigue, muscle pain and swelling in the arm. All the events were considered as non-serious. The outcome of the events was unknown.  No follow-up attempts are possible, information about batch number cannot be obtained.
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia, Middle insomnia, Pain in extremity
Clinical narrative: Severe pain in both shoulders and arms; Severe pain in both shoulders and arms; This pain is so great, it keeps me awake at night; This is a spontaneous report from a contactable consumer (patient). This 86-year-old consumer of an unspecified gender received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 12Feb2021 (Batch/Lot number was not reported) as single dose for COVID-19 immunisation.  Relevant medical history and concomitant medications were not reported. The patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 22Jan2021 for COVID-19 immunisation. One week after the second dose, in Feb2021, the patient developed severe pain in both shoulders and arms. This pain was so great, it kept the patient awake at night, and if he/she got to sleep, it woke him/her up. The patient tried to get relief by "rubbing" all day and taking Tylenol Extra Strength (2 tablets every 6 hours as prescribed). This slightly helped, but it was very temporally. The pain was so great, it was difficult to pick up a cup of coffee. The outcome of the events was unknown.  No follow-up attempts are possible, information about batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Malaise, Nausea, Pyrexia
Clinical narrative: feels unwell; joint pain; fever; nausea; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer reported that a female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. Relevant medical history and concomitant medications were not reported. On an unspecified date, the patient experienced feels unwell, joint pain, fever and nausea; all the events were considered as non-serious. The outcome of the events was unknown.  No follow-up attempts are possible, information about batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: severe pain; This is a spontaneous report from a Pfizer sponsored program. A contactable female consumer of an unspecified age (patient) reported that she received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. Relevant medical history and concomitant medications were not reported. On an unspecified date, the patient experienced severe pain. The patient specified that she was due to get second dose next Friday but she was in severe pain because both shoulders need to get replaced. The patient asked how long until she can take steroid injections and how safe was to travel after getting the vaccine. The outcome of the event was unknown.  No follow-up attempts are possible, information about batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot
Clinical narrative: Her arm was red and warm; Her arm was red and warm; This is a spontaneous report received from a contactable female consumer (patient) of an unspecified age received the first dose of BNT162B2 (Pfizer-Biontech Covid-19 Vaccine) at single dose, on an unspecified date, for COVID-19 immunization. Relevant medical history and concomitant medications were unknown. On 19Mar2021, her arm was red and warm. Clinical outcome of the adverse events was unknown at time of this report.   No follow-up attempts are possible, information about lot number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: tested positive for COVID-19 in a PCR test; This is a spontaneous report from a contactable consumer or other non hcp.   A male patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Lot number and expiry date was not reported) via an unspecified route of administration on 11Mar2021 as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported that on 19Mar2021, the patient tested positive for COVID-19 in a PCR test. The reporter asked if it would be possible to get infected before or after getting the first dose. The reporter asked when the patient could take the second dose. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 19Mar2021. The outcome of event was unknown.  No follow-up attempts are needed. No further information is expected.
Sex: M
Vaccine: COVID19, UNK
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: then was tested positive for covid; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer reported for a male patient (Brother-in-law):  A male patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot number was unknown), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization; and patient was taking hydrocortisone, neomycin sulfate, polymyxin b sulfate (CORTISPORIN, lot number unknown), via unspecified route of administration, from an unspecified start and stop date, for an unspecified indication. The patient medical history and concomitant medications were not reported. The reporter stated that patient was exposed and 2 days later got the vaccine and then was tested positive for COVID. The reporter stated that the patient was in ER at the time of reporting and wanted to know if the vaccine would help him. The reporter wanted to know if patient should get the second dose. The patient underwent lab tests and procedures which included SARS-CoV-2 test: Positive on an unspecified date. The outcome of the event was unknown.  No follow-up attempts are possible; information about batch/ lot number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: He tested positive of Covid 19 vaccine last 23Mar.; This is a spontaneous report from a contactable consumer (patient) via a Pfizer-sponsored program. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 17Mar2021 as 1st dose, single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported that he got the first dose last 17Mar and second dose was scheduled on 14Apr (past 21 days). He tested positive of Covid 19 vaccine last 23Mar2021. He was asking if he needs to wait for 45 days before getting the second dose. The patient underwent lab tests and procedures which included Covid 19 (sars-cov-2 test): positive on 23Mar2021. The outcome of event was unknown.  No follow-up attempts are possible; information about batch/ lot number cannot be obtained.